RESUMO
PURPOSE: The purpose of this report was to describe a case with paracentral acute middle maculopathy after oral intake of sumatriptan. METHODS: Case presentation. RESULTS: One patient showed typical findings on fundoscopic examination and optical coherence tomography consistent with paracentral acute middle maculopathy following oral intake of sumatriptan. CONCLUSION: Sumatriptan may be a trigger for paracentral acute middle maculopathy.
Assuntos
Degeneração Macular , Doenças Retinianas , Sumatriptana , Doença Aguda , Administração Oral , Humanos , Degeneração Macular/induzido quimicamente , Degeneração Macular/diagnóstico por imagem , Doenças Retinianas/induzido quimicamente , Doenças Retinianas/diagnóstico por imagem , Sumatriptana/administração & dosagem , Sumatriptana/efeitos adversos , Tomografia de Coerência ÓpticaRESUMO
Purpose: The purpose of this report is to describe a case of bilateral Candida chorioretinitis complicated with choroidal neovascularization (CNV) and effectively treated with combined intravitreal bevacizumab and amphotericin B.Results: An 83-year-old patient was diagnosed with Candida chorioretinitis in both eyes. Optical coherence tomography and fluorescein angiography revealed CNV. Treatment using combined intravitreal bevacizumab and amphotericin B was initiated followed by a 4-weekly regimen of bevacizumab, eventually resulting in the regression of the subretinal fluid and intraretinal edema.Conclusion: Our study supports the combined use of intravitreal bevacizumab and amphotericin B in the management of CNV in Candida chorioretinitis.
